Overview

In-vitro Toxicology Testing Market is estimated to value over USD 9.8 billion by 2027 end and is expected to register a CAGR of over 11% during the forecast period 2020 to 2027.

In-vitro process is used to detect hazardous chemical substances over an isolated part of an organism. It helps in detecting the toxicity levels at early developmental stages of products like cosmetics, drugs and food additives. In-vitro toxicology involved the usage of tissues or cells that are maintained or grown in a controlled laboratory environment to examine the toxic properties of different mixtures and compounds.

This testing method is primarily used for safety evaluation in drug development. It is also used for ranking chemicals based on their potency. Moreover, in-vitro toxicology testing can be used for determining dose-response, absorption, distribution, metabolism, excretion (ADME) and threshold response of drug.

In-vitro Toxicology Testing Market Segmentation:

Depending on the technology, the market is bifurcated into cell culture technology, high throughput technology, OMICS technology and molecular imaging. Cell culture technology segment is expected to witness significant market growth during the forecast period. There have been recent advancements in the exposure of human cell culture along with test systems. This has allowed for the development and expansion of in-vitro assay systems which are demonstrative, predictive and are suitable for toxicity testing of a wide range of chemicals including airborne materials and nanomaterials.

Method-wise, the market is categorised as cellular assays, biochemical assays, ex-vivo and in-silico segment. Ex-vivo method is projected to register a noteworthy growth rate during the forecast period. This is mainly due to the increasing popularity of stem cell therapy which has encouraged scientists to implement this technique.

Based on the type of application, the market is bifurcated into systemic toxicology, dermal toxicity, endocrine disruption and occular toxicity. There are different types of systemic toxicity like sub-acute systemic toxicity, acute systemic toxicity, chronic systemic toxicity and sub-chronic systemic toxicity. Such a plethora of options in one method is the primary reason for the segment to thrive.

Basis the end-use, the market is categorised as pharmaceutical industry, cosmetic & household products, diagnostics, chemical industry and food industry. The chemical industry is anticipated to showcase significant market growth due to the increase in the manufacturing of excipients for pharmaceutical and cosmetics formulations. Furthermore, the presence of a substantial product portfolio for the market will surely trigger the scope of applications of these assays in the industry.

The market is regionally categorised as North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Asia Pacific is projected to showcase significant market growth over the forecast period owing to growing research and development in pharmaceuticals coupled with consistent improvement in healthcare infrastructure. Furthermore, clinical trials are conducted at a relatively low cost than western countries. It is therefore anticipated that many globalised companies will be willing to invest massively in the Asia Pacific region.

Some of the key market players include:

Agilent Technologies Inc., Abbott Laboratories (Alere Inc.), Bio-Rad Laboratories Inc., Merck KGaA, Charles River Laboratories International Inc., Thermo Fisher Scientific Inc., Catalent Inc., Eurofins Scientific, GE Healthcare, Quest Diagnostics Inc., LabCorp and EVOTEC.

In-vitro Toxicology Testing Market Segmentation:

By Technology

Cell Culture Technology
High Throughput Technology
Molecular Imaging
OMICS Technology

By Method

Cellular Assays
Biochemical Assays
In-silico
Ex-vivo

By Application

Systemic Toxicology
Dermal Toxicity
Endocrine Disruption
Occular Toxicity

By End Use

Pharmaceutical Industry
Cosmetic & Household Products
Diagnostics
Chemical Industry
Food Industry

By Region

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Key Takeaways:

Animal welfare agencies are considering to completely replace conventional animal testing to in-vitro toxicology testing method and this paradigm shift will surely augment the market significantly

Objectives of the Study:

To provide with an exhaustive analysis on the in-vitro toxicology testing market by technology, by method, by application, by end use and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com